Register Online

Accreditation

The Office of Continuing Education and Professional Development (CEPD), Faculty of Medicine, University of Toronto, is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME), a subcommittee of the Committee on Accreditation of Canadian Medical Schools (CACMS). This standard allows the Office of CEPD to assign credits for educational activities based on the criteria established by The College of Family Physicians of Canada, and the Royal College of Physicians and Surgeons of Canada.

Additionally, the Accreditation Council for Continuing Medical Education of the United States (ACCME) maintains a reciprocity relationship with CACME, which the American Medical Association (AMA) recognizes for the purpose of allowing Canadian medical schools the ability to accredit activities for AMA PRA Category 1. As a result of a reciprocal agreement between the AMA and the European Accreditation Council for CME (EACCME), this agreement permits the Office of CEPD to assign EACCME credits.

Letters of Accreditation/Attendance

Letters of accreditation/attendance will be available online following the course. Participants will be emailed information within two weeks specifying how to obtain their letter of accreditation/attendance online.

Faculty Disclosure

It is the policy of University of Toronto, Faculty of Medicine, Continuing Professional Development to ensure balance, independence, objectivity, and scientific rigor in all its individually accredited or jointly accredited educational programs. Speakers and/or planning committee members, participating in University of Toronto accredited programs, are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships within the last FIVE (5) years with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts. It remains for the audience to determine whether the speaker's outside interests may reflect a possible bias in either the exposition or the conclusions presented.

Faculty Disclosure Statements

The following speakers and planning committee members have disclosed the following:

Drs. Vinod Chandran, Lihi Eder, James T. Elder, Vern Farewell, Dafna Gladman, Philip Helliwell, Proton Rahman and Carter Thorne have/had no financial interest/arrangement or affiliation with one or more organizations that could be perceived as a related or apparent conflict of interest in the context of the subject of their presentation.

The following have declared financial interests, arrangements or affiliations with one or more organizations that could be perceived as a related or apparent conflict of interest of the subject of this presentation over the past five (5) years:

Speaker / Committee Grant / Research Support Consultant Speakers’ Bureau Other Financial / Material Support
Wolf-Henning Boehncke Janssen - role of TH17 cell cytokines in endothelial dysfunction; Wyeth - biomarkers for metabolic and cardiovascular comorbidities Abbot, Biogen Idec, Janssen, Lilly, MSD, Novartis, Pfizer Abbot, Biogen Idec, Janssen, MSD, Pfizer  
Joel Gelfand NIH (NIAMS and NHLBI), Abbrie, Amgen, Novartis, Lilly Amgen, Novartis, Abbvie, Janssen, Lilly, Pfizer, Merck    
Alice Gottlieb Via Tufts: Centocor (Janssen), Amgen, Abbot, Novartiz, Celgene, Pfizer, Lilly Amgen, Astellas, Centocor (Janssen), Celgene, Bristol Myers Squibb, Beiersdorf, Abbvie, TEVA, Actelion, UCB, Novo Nordisk, Novartis, Dermipsor, Incyte, Pfizer, Canfite, Lilly, Coronado, Vertex, Karyopharm    
Philip Mease AbbVie, Amgen, Biogen Idec, Bristol Myers Squibb, Celgene, Crescendo, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer, and UCB AbbVie, Amgen, Biogen Idec, Bristol Myers Squibb, Celgene, Crescendo, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer, and UCB AbbVie, Amgen, Biogen Idec, Bristol Myers Squibb, Crescendo, Genentech, Janssen, Lilly, Pfizer, UCB  
Christopher Ritchlin Amgen, Pfizer, Janssen, UCB Abbvie, Amjen, Janssen, Pfizer, Lilly, UCB    
Cheryl Rosen Abbott, AbbVie Labs Amgen Inc., Centocor, Johnson & Johnson, AbbVie Labs, Leo Pharma   AbbVie Labs, Amgen Inc., Johnson & Johnson, Leo Pharma

Continuing Education and Professional Development
Faculty of Medicine, University of Toronto
500 University Avenue, Suite 650 Toronto, Ontario, M5G 1V7
Tel: 416.978.2719 / Toll free: 1.888.512.8173

Email: info-MED1360@cepdtoronto.ca